Valuation: Crossject

Market Cap 71.32M 79.95M 66.45M 60.47M 114M 7.7B 115M 803M 312M 3.93B 300M 294M 12.63B P/E 2026 *
3.2x
P/E 2027 * 2.52x
Enterprise Value 53.42M 59.88M 49.77M 45.29M 85.29M 5.77B 85.93M 601M 234M 2.94B 225M 220M 9.46B EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.37x
Free-Float
92.46%
Yield 2026 *
-
Yield 2027 * -
1 week-1.95%
Current month-5.07%
1 month-2.24%
3 months-27.22%
6 months-35.94%
Current year-40.18%
1 week 1.28
Extreme 1.284
1.41
1 month 1.19
Extreme 1.188
1.44
Current year 1.19
Extreme 1.188
2.58
1 year 1.19
Extreme 1.188
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
7.25
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
04/07/25 Buy

Director

13,386 0.0266%
01/07/25 Buy

Director

50 0.0001%
01/07/25 Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.95%-35.63%-65.44% 80.27M
+2.67%-0.87%-25.15%+4.05% 169B
+1.84%-1.71%-10.63%+15.52% 110B
+3.55%+3.60%-22.13%+7.71% 106B
+1.19%+0.42%-48.90%-11.41% 73.87B
+1.90%+3.66%+3.15%+70.20% 58.98B
+1.32%+4.32%+14.41%+64.37% 51.28B
+2.19%-1.72%-5.90%-30.79% 48.16B
+1.67%-0.38%-16.04%+22.43% 40.84B
+1.80%+0.25%+30.95%+3.45% 32.21B
Average +1.67%-0.97%-11.59%+8.01% 69.03B
Weighted average by Cap. +2.00%-1.30%-15.05%+13.55%

Financials

2026 *2027 *
Net sales 60.8M 68.15M 56.64M 51.55M 97.07M 6.56B 97.79M 684M 266M 3.35B 256M 250M 10.77B 65.2M 73.09M 60.74M 55.28M 104M 7.04B 105M 734M 286M 3.59B 274M 268M 11.55B
Net income 28.3M 31.72M 26.37M 23.99M 45.18M 3.06B 45.52M 319M 124M 1.56B 119M 117M 5.01B 35.6M 39.91M 33.17M 30.18M 56.84M 3.84B 57.26M 401M 156M 1.96B 150M 147M 6.31B
Net Debt -17.9M -20.07M -16.68M -15.18M -28.58M -1.93B -28.79M -202M -78.4M -986M -75.32M -73.7M -3.17B -47M -52.68M -43.79M -39.85M -75.04M -5.07B -75.6M -529M -206M -2.59B -198M -194M -8.32B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
05/10/26 €1.310 0.00% 62,564
02/10/26 €1.310 -2.96% 119,215
01/10/26 €1.350 -2.17% 88,486
30/09/26 €1.380 +2.22% 85,077
29/09/26 €1.350 +6.13% 230,216
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.310EUR
Average target price
4.400EUR
Spread / Average Target
+235.88%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock